BERTOLDI, GIOVANNI
BERTOLDI, GIOVANNI
Dipartimento di Medicina - DIMED
ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman’s and Bartter’s Syndromes.
2021 Calò, Lorenzo A.; Rigato, Matteo; Sgarabotto, Luca; Gianesello, Lisa; Bertoldi, Giovanni; Ravarotto, Verdiana; Davis, Paul A.
ACE2, Rho kinase inhibition and the potential role of vitamin D against COVID-19.
2020 Bertoldi, Giovanni; Gianesello, Lisa; Calo', Lorenzo
ACE2/Angiotensin 1-7 protective anti-inflammatory and antioxidant role in hyperoxic lung injury: support from studies in Bartter's and Gitelman's syndromes
2020 Calo', Lorenzo; Rigato, Matteo; Bertoldi, Giovanni
Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?
2023 Bertoldi, Giovanni; Caputo, Ilaria; Driussi, Giulia; Stefanelli, Lucia Federica; Di Vico, Valentina; Carraro, Gianni; Nalesso, Federico; Calò, Lorenzo A.
Calcineurin-Inhibitor-Induced Hypomagnesemia in Kidney Transplant Patients: A Monocentric Comparative Study between Sucrosomial Magnesium and Magnesium Pidolate Supplementation.
2023 Stefanelli, Lf; Alessi, M; Bertoldi, G; Rossato, V; Di Vico, V; Nalesso, F; Calò, La.
Could nutritional therapy take us further in our approaches to Fabry disease?
2019 Francini-Pesenti, Francesco; Ravarotto, Verdiana; Bertoldi, Giovanni; Spinella, Paolo; Calò, Lorenzo A.
Effects of Tolvaptan on Oxidative Stress in ADPKD: A Molecular Biological Approach
2022 Rigato, Matteo; Carraro, Gianni; Cirella, Irene; Dian, Silvia; DI VICO, Valentina; Stefanelli, LUCIA FEDERICA; Ravarotto, Verdiana; Bertoldi, Giovanni; Nalesso, Federico; Calò, Lorenzo A.
Gitelman’s and Bartter’s syndromes: from genetics to the molecular basis of hypertension and more.
2022 Ravarotto, V; Bertoldi, G; Stefanelli, Lf; Nalesso, F; Calò, La
Impaired ACE2 glycosylation and protease activity in Fabry disease protects from COVID-19.
2023 Caputo, I; Bertoldi, G; Driussi, G; Sgarabotto, L; Carraro, G; Stefanelli, Lf; Davis, Pa; Calò, La.
Impaired ACE2 glycosylation and protease activity lowers COVID-19 susceptibility in Gitelman’s and Bartter’s syndromes.
2021 Bertoldi, Giovanni; Ravarotto, Verdiana; Sgarabotto, Luca; A Davis, Paul; Calo', Lorenzo
Lymphatic vessels and the renin-angiotensin-system
2023 Bertoldi, G; Caputo, I; Calo, L; Rossitto, G.
Molecular aspects of the altered Angiotensin II signaling in Gitelman’s syndrome
2022 Ravarotto, Verdiana; Bertoldi, Giovanni; Stefanelli, LUCIA FEDERICA; Gobbi, Laura; Calò, Lorenzo A.
On the imbalanced protective arm of RAS in COVID-19: Lesson from rare genetic tubulopathies
2021 Davis, Pa; Bertoldi, G; Calò, La
Oxidative Stress and Cardiovascular-Renal Damage in Fabry Disease: Is There Room for a Pathophysiological Involvement?
2018 Ravarotto, Verdiana; Simioni, Francesca; Carraro, Gianni; Bertoldi, Giovanni; Pagnin, Elisa; Calò, Lorenzo A.; Bertoldi, Giovanni
Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling?
2018 Ravarotto, Verdiana; Carraro, Gianni; Pagnin, Elisa; Bertoldi, Giovanni; Simioni, Francesca; Maiolino, Giuseppe; Martinato, Matteo; Landini, Linda; A Davis, Paul; Calo', Lorenzo
Oxidative stress, inflammation and peritoneal dialysis: a molecular biology approach.
2021 Innico, Georgie; Gobbi, Laura; Bertoldi, Giovanni; Rigato, Matteo; Basso, Anna; Bonfante, Luciana; Calo', Lorenzo
P1190 Oxidative stress and inflammation in peritoneal dialysis: dangerous and to be solved.
2020 Innico, G; Bertoldi, G; Alessi, M; Pagnin, E; Simeone, M; Baboci, G; Bonfante, L; Calò, La
Pathomechanism of oxidative stress in cardiovascularrenal remodeling and therapeutic strategies.
2022 Ravarotto, Verdiana; Bertoldi, Giovanni; Stefanelli, LUCIA FEDERICA; Nalesso, Federico; Calo', Lorenzo
Rare genetic tubulopathies Gitelman's and Bartter's syndromes and their naturally occurring protection from COVID-19.
2022 Sgarabotto, Luca; Gianesello, Lisa; Bertoldi, Giovanni; Nalesso, Federico; Stefanelli, LUCIA FEDERICA; Calò, Lorenzo.
Reduced oxidative stress in ADPKD patients treated with tolvaptan.
2022 Rigato, M; Carraro, G; Cirella, I; Dian, S; Di Vico, V; Ravarotto, V; Bertoldi, G; Calò, La.